BlackRock Fund Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

BlackRock Fund Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.12M	Sell	634,650 -369,261	-37%	-$1.89M	﹤0.01%	3073
2016 Q3	$4.98M	Buy	1,003,911 +53,370	+6%	+$273K	﹤0.01%	2846
2016 Q2	$4.84M	Buy	950,541 +3,818	+0.4%	+$20.6K	﹤0.01%	2833
2016 Q1	$5.41M	Buy	946,723 +36,876	+4%	+$258K	﹤0.01%	2703
2015 Q4	$9.44M	Sell	909,847 -83,855	-8%	-$1.14M	﹤0.01%	2480
2015 Q3	$18.4M	Buy	993,702 +41,473	+4%	+$800K	﹤0.01%	2044
2015 Q2	$18.5M	Sell	952,229 -13,731	-1%	-$243K	﹤0.01%	2156
2015 Q1	$17M	Buy	965,960 +29,130	+3%	+$489K	﹤0.01%	2152
2014 Q4	$15M	Buy	936,830 +64,200	+7%	+$860K	﹤0.01%	2230
2014 Q3	$11M	Sell	872,630 -861	-0.1%	-$12.3K	﹤0.01%	2292
2014 Q2	$13.6M	Sell	873,491 -11,488	-1%	-$169K	﹤0.01%	2226
2014 Q1	$11.6M	Buy	884,979 +43,960	+5%	+$688K	﹤0.01%	2313
2013 Q4	$13.5M	Buy	841,019 +14,483	+2%	+$231K	﹤0.01%	2203
2013 Q3	$13.8M	Buy	826,536 +107,274	+15%	+$1.59M	﹤0.01%	2169
2013 Q2	$7.24M	Buy	+719,262	New	+$7.56M	﹤0.01%	2462

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Fund Advisors's OSIR Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Osiris Therapeutics, Inc. Common Stock (OSIR) stake by 37% in Q4 2016, selling an estimated $1.89M and leaving 634,650 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

BlackRock Fund Advisors first reported a position in OSIR in Q2 2013 and has held it in 15 quarters since. The position peaked at $18.5M in Q2 2015. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

BlackRock Fund Advisors held 634,650 shares of Osiris Therapeutics, Inc. Common Stock worth $3.12M as of Q4 2016.
BlackRock Fund Advisors sold 369,261 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.89M.
Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3073 holding.
BlackRock Fund Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $18.5M in Q2 2015.
64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.